Targeting cell growth in BRCA1 cancer

Lead researcher

A/Prof Grant McArthur

Institution

Peter MacCallum Cancer Centre, Divisions of Research & Clinical Haematology/Medical Oncology

Years funded

2005-2007

Breast cancer is the second most common cancer in Australian women. We propose that breast cancers associated with the inherited breast cancer gene BRCA1 display unique cellular and molecular features that we can use to develop new and highly specific treatments. We will determine if BRCA1 cancers are especially sensitive to drugs that target a molecule CDK2 when used alone or in combination with other cancer therapies.

Targeting cell growth in BRCA1 cancer

Award / Duration

Duration: 2005-2007

Funding

$70,000 per annum for 3 years